INTRODUCTION: Patients with invasive ovarian cancer were recently shown to have a higher frequency of skewed X chromosome inactivation in peripheral blood cells compared to patients with borderline cancer and controls. In this study, we analysed the X inactivation pattern in peripheral blood from 216 breast cancer patients. METHODS: X inactivation analysis was performed using HpaII predigestion of DNA followed by PCR of the highly polymorphic CAG repeat of the androgen receptor gene (AR), which amplifies the undigested inactive X chromosome only. The X inactivation pattern was classified as skewed when 90% or more of the cells preferentially used one X chromosome. RESULTS: Young breast cancer patients (27-45 years) had a higher frequency of skewed X inactivation than young controls (13 and 1%, respectively) (p=0.009), whereas no difference was found for middle aged and older patients compared to controls of a similar age. CONCLUSIONS: A germline mutation in an X linked tumour suppressor gene may give a proliferative advantage to cells with this mutation on the active X chromosome, thus causing skewed X inactivation and an increased risk for developing cancer. Another possible explanation could be that females with a constitutionally skewed X inactivation pattern are more susceptible to develop breast cancer because of an X linked low penetrance susceptibility allele that is affected by the inactivation pattern.
INTRODUCTION:Patients with invasive ovarian cancer were recently shown to have a higher frequency of skewed X chromosome inactivation in peripheral blood cells compared to patients with borderline cancer and controls. In this study, we analysed the X inactivation pattern in peripheral blood from 216 breast cancerpatients. METHODS: X inactivation analysis was performed using HpaII predigestion of DNA followed by PCR of the highly polymorphic CAG repeat of the androgen receptor gene (AR), which amplifies the undigested inactive X chromosome only. The X inactivation pattern was classified as skewed when 90% or more of the cells preferentially used one X chromosome. RESULTS: Young breast cancerpatients (27-45 years) had a higher frequency of skewed X inactivation than young controls (13 and 1%, respectively) (p=0.009), whereas no difference was found for middle aged and older patients compared to controls of a similar age. CONCLUSIONS: A germline mutation in an X linked tumour suppressor gene may give a proliferative advantage to cells with this mutation on the active X chromosome, thus causing skewed X inactivation and an increased risk for developing cancer. Another possible explanation could be that females with a constitutionally skewed X inactivation pattern are more susceptible to develop breast cancer because of an X linked low penetrance susceptibility allele that is affected by the inactivation pattern.
Authors: T R Rebbeck; P W Kantoff; K Krithivas; S Neuhausen; M A Blackwood; A K Godwin; M B Daly; S A Narod; J E Garber; H T Lynch; B L Weber; M Brown Journal: Am J Hum Genet Date: 1999-05 Impact factor: 11.025
Authors: K H Orstavik; R E Orstavik; A K Naumova; P D'Adamo; A Gedeon; P A Bolhuis; P G Barth; D Toniolo Journal: Am J Hum Genet Date: 1998-11 Impact factor: 11.025
Authors: Jonas Mengel-From; Mikael Thinggaard; Lene Christiansen; James W Vaupel; Karen Helene Orstavik; Kaare Christensen Journal: Eur J Hum Genet Date: 2011-12-07 Impact factor: 4.246
Authors: Steven Hecht Orzack; J William Stubblefield; Viatcheslav R Akmaev; Pere Colls; Santiago Munné; Thomas Scholl; David Steinsaltz; James E Zuckerman Journal: Proc Natl Acad Sci U S A Date: 2015-03-30 Impact factor: 11.205
Authors: J P Struewing; M A Pineda; M E Sherman; J Lissowska; L A Brinton; B Peplonska; A Bardin-Mikolajczak; M Garcia-Closas Journal: J Med Genet Date: 2005-05-27 Impact factor: 6.318
Authors: Lori C Sakoda; Christie R Blackston; Jennifer A Doherty; Roberta M Ray; Ming Gang Lin; Dao Li Gao; Helge Stalsberg; Ziding Feng; David B Thomas; Chu Chen Journal: Cancer Epidemiol Date: 2010-09-17 Impact factor: 2.984